New York, NY, United States of America

Hyung Don Ryoo


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyung Don Ryoo: Innovator in Apoptosis Regulation

Introduction

Hyung Don Ryoo is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cell death regulation through his innovative research and patents. His work focuses on the mechanisms of apoptosis, which is crucial for understanding various biological processes and diseases.

Latest Patents

Hyung Don Ryoo holds a patent for "Peptides and methods for cell death regulation." This invention provides novel peptides, nucleic acids, compounds, compositions, and methods for regulating apoptosis. The patent outlines screening methods for identifying these components. The regulation of apoptosis is mediated via IAPi-derived proteins and peptide fragments, which can stimulate or suppress apoptosis. The stimulation of apoptosis leads to self-ubiquitination and auto-degradation of an IAP, while suppression involves IAPi-derived proteins that fail to stimulate self-ubiquitination.

Career Highlights

Throughout his career, Hyung Don Ryoo has worked with esteemed institutions such as the Rappaport Family Institute for Research in the Medical Sciences and the Rockefeller Institute. His research has contributed to a deeper understanding of apoptosis and its implications in medical science.

Collaborations

Hyung Don Ryoo has collaborated with prominent scientists, including Hermann Steller and Aaron J. Ciechanover. These collaborations have further advanced the research in the field of apoptosis and its regulatory mechanisms.

Conclusion

Hyung Don Ryoo's innovative work in apoptosis regulation has led to significant advancements in understanding cell death mechanisms. His contributions through patents and collaborations continue to impact the field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…